Creating Value for Life Science Research!

Get a Free Sample of this product!
shopping cart image

Anti-Human TNF-β

Catalog Number : 500-P31B


Produced from sera of rabbits pre-immunized with highly pure recombinant Human TNF-β. Anti-Human TNF-β specific antibody was purified by affinity chromatography employing immobilized Human TNF-β matrix.

Additional Information

Recombinant Human TNF-β (E.coli-derived) (BioGems Catalog #300-01B)
Polyclonal Rabbit
This antibody stained formalin-fixed, paraffin-embedded sections of human breast malignant carcinoma.  The recommended concentration is 0.50 µg/mL with an overnight incubation at 4˚C.  An HRP-labeled polymer detection system was used with a DAB chromogen.  Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended.  Optimal concentrations and conditions may vary.  
 Tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute. 
To yield one-half maximal inhibition [ND50] of the biological activity of Human TNF-β (0.5 ng/ml), a concentration of < 0.1 μg/ml of this antibody is required.
Sandwich ELISA:
To detect Human TNF-β by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems' Biotinylated Anti-Human TNF-β (60-325BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human TNF-β.
Western Blot:
To detect Human TNF-β by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human TNF-β is 1.5-3.0 ng/lane, under either reducing non-reducing conditions.

Availability: In stock

Size Price Qty